Clearmind Medicine Inc. Share Price
NASDAQ: CMNDClearmind Medicine Inc. Stock Performance
Clearmind Medicine Inc. Share Price Today
As of 9 October 2026, Clearmind Medicine Inc.'s share price is $6.37. The stock opened at $6.08, compared to its previous close of $5.80. During today's trading session, Clearmind Medicine Inc.'s share price traded between $6.08 and $6.08, with an average price of $6.08. Over the past 52 weeks, the stock has recorded a high of $6.08 and a low of $0.07. In terms of performance, Clearmind Medicine Inc.'s share price has risen by 802.27% over the last six months and is up 738.16% on a year-on-year basis.
Clearmind Medicine Inc. Share Price Chart
Clearmind Medicine Inc. Annual Profit & Loss
All figures in USD
About Clearmind Medicine Inc.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
Clearmind Medicine Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $0.71 | $6.08 | +655.28% |
Sep 2026 | $1.82 | $0.81 | -54.00% |
Aug 2026 | $1.54 | $1.75 | +10.76% |
Jul 2026 | $2.31 | $1.58 | -33.89% |
Jun 2026 | $2.89 | $2.39 | -31.71% |
May 2026 | $0.69 | $3.50 | +395.75% |
Apr 2026 | $1.01 | $0.71 | -28.18% |
Mar 2026 | $1.18 | $0.98 | -15.26% |
Feb 2026 | $2.24 | $1.16 | -46.30% |
Jan 2026 | $2.02 | $2.16 | +20.67% |
Dec 2025 | $0.15 | $1.79 | +1,077.63% |
Nov 2025 | $0.82 | $0.15 | -80.00% |